“Cynomolgus monkeys dosed with 0, 10, 25 or 90 mg/kg/dose SC brodalumab weekly for six months were observed with mild skin changes and histopathology (MD and HD), increased neutrophil counts (HD) and decreased albumin/globulin ratios (MD and HD).”
✓ VerifiedFDA pharmacology/toxicology review, p. 21Source ↗
“In the pivotal repeat dose cynomolgus monkey toxicity study, animals dosed with 0, 10, 25 or 90 mg/kg/dose SC brodalumab weekly for six months were observed with mild skin changes and histopathology (MD and HD)”
✓ VerifiedFDA pharmacology/toxicology review, p. 32Source ↗
Route in tox
Subcutaneous and intravenous
“The NOAEL for this study was determined to be 350 mg/kg/dose for both SC and IV routes of administration.”
✓ VerifiedFDA pharmacology/toxicology review, p. 20Source ↗